FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287880015> ?p ?o ?g. }

• W4287880015 endingPage "249" @default.
• W4287880015 startingPage "243" @default.
• W4287880015 abstract "There are many barriers to physical activity among cancer survivors. Survivors treated with neurotoxic chemotherapy may develop chemotherapy-induced peripheral neuropathy (CIPN) and experience additional barriers related to sensorimotor and mobility deficits. This study examined physical activity behaviors, including physical activity predictors, among cancer survivors treated with neurotoxic chemotherapies.A cross-sectional study of 252 participants, 3-24 months after neurotoxic chemotherapy, was undertaken. Physical activity was self-reported (IPAQ). CIPN was self-reported (FACT/GOG-Ntx-13), clinically graded (NCI-CTCAE), and objectively measured using neurological grading scales and neurophysiological techniques (tibial and sural nerve conduction studies). Balance (Swaymeter) and fine motor skills (grooved pegboard) were assessed. Regression models were used to identify clinical, demographic and CIPN predictors of walking and moderate-vigorous physical activity.Forty-four percent of participants did not meet recommended physical activity guidelines (≥150 min/week). Sixty-six percent presented with CIPN. Nineteen percent of participants with CIPN reported that symptoms interfered with their ability to be physically active. A lower proportion of survivors aged ≥60, with grade ≥1 CIPN or BMI ≥30, reported meeting physical activity guidelines (all p < .05). Regression models identified older age, higher BMI, and patient-reported CIPN associated with lower walking, while higher BMI and females were associated with lower moderate-vigorous physical activity. Neurologically assessed CIPN did not associate with walking or moderate-vigorous physical activity.Cancer survivors exposed to neurotoxic chemotherapy have low physical activity levels. Further work should examine the factors causing physical activity limitations in this cohort and designing interventions to improve physical function and quality of life in survivors." @default.
• W4287880015 created "2022-07-26" @default.
• W4287880015 creator A5006927014 @default.
• W4287880015 creator A5021894535 @default.
• W4287880015 creator A5024353703 @default.
• W4287880015 creator A5036001957 @default.
• W4287880015 creator A5045684532 @default.
• W4287880015 creator A5048164891 @default.
• W4287880015 creator A5064106888 @default.
• W4287880015 creator A5066759495 @default.
• W4287880015 creator A5069452886 @default.
• W4287880015 creator A5072774436 @default.
• W4287880015 creator A5079426234 @default.
• W4287880015 date "2022-07-25" @default.
• W4287880015 modified "2023-09-30" @default.
• W4287880015 title "Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy" @default.
• W4287880015 cites W1547422201 @default.
• W4287880015 cites W1968626722 @default.
• W4287880015 cites W1973155534 @default.
• W4287880015 cites W1973892020 @default.
• W4287880015 cites W1982345758 @default.
• W4287880015 cites W2004441491 @default.
• W4287880015 cites W2026047320 @default.
• W4287880015 cites W2052474858 @default.
• W4287880015 cites W2059786204 @default.
• W4287880015 cites W2069018552 @default.
• W4287880015 cites W2074685643 @default.
• W4287880015 cites W2096491215 @default.
• W4287880015 cites W2099210388 @default.
• W4287880015 cites W2107263116 @default.
• W4287880015 cites W2127867324 @default.
• W4287880015 cites W2143341124 @default.
• W4287880015 cites W2158659583 @default.
• W4287880015 cites W2171129594 @default.
• W4287880015 cites W2200049143 @default.
• W4287880015 cites W2266999193 @default.
• W4287880015 cites W2461469327 @default.
• W4287880015 cites W2529202618 @default.
• W4287880015 cites W2557532819 @default.
• W4287880015 cites W2560268504 @default.
• W4287880015 cites W2588290358 @default.
• W4287880015 cites W2591526702 @default.
• W4287880015 cites W2615584788 @default.
• W4287880015 cites W2768608541 @default.
• W4287880015 cites W2769024299 @default.
• W4287880015 cites W2774164535 @default.
• W4287880015 cites W2802859888 @default.
• W4287880015 cites W2810376202 @default.
• W4287880015 cites W2913207660 @default.
• W4287880015 cites W2964928975 @default.
• W4287880015 cites W2967146499 @default.
• W4287880015 cites W2981263606 @default.
• W4287880015 cites W3009132028 @default.
• W4287880015 cites W3011585595 @default.
• W4287880015 cites W3014124313 @default.
• W4287880015 cites W3030414837 @default.
• W4287880015 cites W3092812081 @default.
• W4287880015 cites W3192337264 @default.
• W4287880015 cites W4214564623 @default.
• W4287880015 cites W4220853287 @default.
• W4287880015 cites W4294116629 @default.
• W4287880015 doi "https://doi.org/10.1111/ajco.13834" @default.
• W4287880015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35879821" @default.
• W4287880015 hasPublicationYear "2022" @default.
• W4287880015 type Work @default.
• W4287880015 citedByCount "1" @default.
• W4287880015 countsByYear W42878800152023 @default.
• W4287880015 crossrefType "journal-article" @default.
• W4287880015 hasAuthorship W4287880015A5006927014 @default.
• W4287880015 hasAuthorship W4287880015A5021894535 @default.
• W4287880015 hasAuthorship W4287880015A5024353703 @default.
• W4287880015 hasAuthorship W4287880015A5036001957 @default.
• W4287880015 hasAuthorship W4287880015A5045684532 @default.
• W4287880015 hasAuthorship W4287880015A5048164891 @default.
• W4287880015 hasAuthorship W4287880015A5064106888 @default.
• W4287880015 hasAuthorship W4287880015A5066759495 @default.
• W4287880015 hasAuthorship W4287880015A5069452886 @default.
• W4287880015 hasAuthorship W4287880015A5072774436 @default.
• W4287880015 hasAuthorship W4287880015A5079426234 @default.
• W4287880015 hasBestOaLocation W42878800151 @default.
• W4287880015 hasConcept C126322002 @default.
• W4287880015 hasConcept C134018914 @default.
• W4287880015 hasConcept C1862650 @default.
• W4287880015 hasConcept C2779289229 @default.
• W4287880015 hasConcept C2779901536 @default.
• W4287880015 hasConcept C3020255362 @default.
• W4287880015 hasConcept C555293320 @default.
• W4287880015 hasConcept C71924100 @default.
• W4287880015 hasConcept C72563966 @default.
• W4287880015 hasConcept C99508421 @default.
• W4287880015 hasConceptScore W4287880015C126322002 @default.
• W4287880015 hasConceptScore W4287880015C134018914 @default.
• W4287880015 hasConceptScore W4287880015C1862650 @default.
• W4287880015 hasConceptScore W4287880015C2779289229 @default.
• W4287880015 hasConceptScore W4287880015C2779901536 @default.
• W4287880015 hasConceptScore W4287880015C3020255362 @default.
• W4287880015 hasConceptScore W4287880015C555293320 @default.
• W4287880015 hasConceptScore W4287880015C71924100 @default.

• next